Skip to main content
. 2022 Sep 6;2022:7255331. doi: 10.1155/2022/7255331

Table 4.

Regression analysis of FA supplementation and HDCP and preeclampsia (0.4FA group as reference).

Early pregnancy (n = 7461) Whole pregnancy (n = 2173)
0.4 FA (n = 5177) MV + 0.4 FA (n = 1274) MV + 0.8 FA (n = 3183) 0.4 FA (n = 5177) MV + 0.4 FA (n = 1274) MV + 0.8 FA (n = 3183)
HDCP
Crude RR(95% CI) 1 1.05 (0.66-1.67) 0.60 (0.41-0.87) 1 0.95 (0.49-1.82) 0.67 (0.40-1.17)
P 0.834 0.008 0.871 0.163
Model RR(95% CI) 1 1.12 (0.70-1.79) 0.60 (0.41-0.88) 1 0.98 (0.50-1.90) 0.77 (0.45-1.31)
P 0.635 0.009 0.942 0.337

Preeclampsia
Crude RR(95% CI) 1 1.35 (0.62-2.94) 0.18 (0.06-0.60) 1 1.34 (0.47-3.81) 0.76 (0.29-1.96)
P 0.457 0.005 0.586 0.568
Model RR(95% CI) 1 1.42 (0.65-3.12) 0.18 (0.06-0.59) 1 1.38 (0.48-3.95) 0.85 (0.33-2.20)
P 0.381 0.005 0.551 0.735

Crude: without adjusting for any covariates. Model: adjusted for education, prepregnancy BMI, age, weight gain during pregnancy, ethnicity, infant gender, and primiparity. FA: folic acid, 0.4 FA: 0.4 mg folic acid, MV + 0.4 FA: multivitamins with 0.4 mg folic acid, MV + 0.8 FA: multivitamins with 0.8 mg folic acid. P < 0.05.